Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
May 23 2019
Lille, June 25-26th 2019: As Defymed won the “Start-up Slams” contest in MEDFIT Strasbourg last year...
April 26 2019
Paris, May 14th 2019: We are very happy to participate to this innovative start-up day organized by...